Biohaven Ltd. (BHVN)

Biohaven Statistics

Total Valuation

Biohaven has a market cap or net worth of $1.74 billion. The enterprise value is $1.45 billion.

Market Cap	1.74B
Enterprise Value	1.45B

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Biohaven has 102.11 million shares outstanding. The number of shares has increased by 29.20% in one year.

Current Share Class	102.11M
Shares Outstanding	102.11M
Shares Change (YoY)	+29.20%
Shares Change (QoQ)	+0.88%
Owned by Insiders (%)	11.54%
Owned by Institutions (%)	85.12%
Float	84.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	28.70
PB Ratio	6.37
P/TBV Ratio	7.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.14.

Current Ratio	2.33
Quick Ratio	1.97
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -316.82% and return on invested capital (ROIC) is -181.93%.

Return on Equity (ROE)	-316.82%
Return on Assets (ROA)	-129.99%
Return on Invested Capital (ROIC)	-181.93%
Return on Capital Employed (ROCE)	-309.43%
Revenue Per Employee	n/a
Profits Per Employee	-$3.47M
Employee Count	256
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Biohaven has paid $775,000 in taxes.

Income Tax	775,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.34% in the last 52 weeks. The beta is 3.64, so Biohaven's price volatility has been higher than the market average.

Beta (5Y)	3.64
52-Week Price Change	-51.34%
50-Day Moving Average	19.19
200-Day Moving Average	35.85
Relative Strength Index (RSI)	46.37
Average Volume (20 Days)	2,330,948

Short Selling Information

The latest short interest is 8.17 million, so 8.00% of the outstanding shares have been sold short.

Short Interest	8.17M
Short Previous Month	7.69M
Short % of Shares Out	8.00%
Short % of Float	9.65%
Short Ratio (days to cover)	3.38

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-912.53M
Pretax Income	-750.36M
Net Income	-888.60M
EBITDA	-903.88M
EBIT	-912.53M
Earnings Per Share (EPS)	-$9.23

Balance Sheet

The company has $322.75 million in cash and $35.51 million in debt, giving a net cash position of $287.24 million or $2.81 per share.

Cash & Cash Equivalents	322.75M
Total Debt	35.51M
Net Cash	287.24M
Net Cash Per Share	$2.81
Equity (Book Value)	259.50M
Book Value Per Share	2.54
Working Capital	218.72M

Cash Flow

In the last 12 months, operating cash flow was -$644.94 million and capital expenditures -$4.07 million, giving a free cash flow of -$649.01 million.

Operating Cash Flow	-644.94M
Capital Expenditures	-4.07M
Free Cash Flow	-649.01M
FCF Per Share	-$6.36

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biohaven does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.20%
Shareholder Yield	-29.20%
Earnings Yield	-51.20%
FCF Yield	-37.40%

Analyst Forecast

The average price target for Biohaven is $59.85, which is 251.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$59.85
Price Target Difference	251.44%
Analyst Consensus	Strong Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	6.05%
EPS Growth Forecast (5Y)	-23.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1